Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans [Phase 4]
Phase 4 trial update evaluating the effects of SGLT-2 inhibition on sympathetic nervous system activity in humans with metabolic syndrome an…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Mindfulness IN-home for Diabetes and Sleep Health [NA]
Clinical trial update for an in-home mindfulness program for individuals with type 2 diabetes, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial assessing alirocumab's effect on postprandial hyperlipemia in patients with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Efficacy of Trimetazidine in Diabetic Patients [Phase 2]
Phase 2 trial update evaluating the efficacy of trimetazidine in type 2 diabetes and diabetic cardiomyopathy.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women [Phase 1]
Phase 1 trial examining how diabetes interacts with estradiol to affect human brain metabolism in postmenopausal women; results have been po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial evaluating the effects of tirzepatide in combination with insulin glargine on glucolipid metabolism and brain functio…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy [Phase 3]
Phase 3 clinical trial update evaluating efficacy and safety of different regimens in patients with type 2 diabetes mellitus on intensive in…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Physical Activity and Participation [NA]
A completed clinical trial evaluating physical activity and participation in individuals with Type 2 Diabetes Mellitus; results posted in 20…
-
EMA approval · 2022-09-09EMA Authorised: Incresync (alogliptin;pioglitazone) — Takeda Pharma A/S
The EMA authorised Incresync, a combination product of alogliptin and pioglitazone, for type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With T2 Diabetes [NA]
A completed clinical trial evaluating a virtual self-care and education program for Latinos with type 2 diabetes; results were posted in 202…
-
EMA withdrawal · 2022-08-30EMA Withdrawn: Pioglitazone Teva Pharma (pioglitazone hydrochloride) — Teva Pharma B.V.
The EMA has withdrawn the pioglitazone hydrochloride product Teva Pharma B.V. from the market.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes [NA]
Clinical trial update for Gelesis100 in overweight and obese adults, with and without Type 2 diabetes, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Type 2 Diabetes Mellitus Prevention Ukraine [Phase 2]
Phase 2 trial update in Ukraine evaluating prevention of type 2 diabetes mellitus in individuals with impaired fasting glucose or impaired g…
-
CLINICAL_TRIALS withdrawal · 2022-08-26Clinical Trial Update: Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy [Phase 4]
A Phase 4 clinical trial examining an intervention for high-normal blood pressure in adults with type 2 diabetes has been withdrawn.
-
FDA approval · 2022-08-19FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (VistaPharm, LLC)
FDA approved an original application for metformin hydrochloride as a generic product manufactured by VistaPharm, LLC.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk [Phase 3]
Phase 3 trial update on an SGLT-2 inhibitor assessing effects on myocardial perfusion, function, and metabolism in type 2 diabetes patients …
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: T2DXcel Mobile Application [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial update for the T2DXcel mobile application in adults with Type 2 diabetes; study status is completed.
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of DBPR108 100 mg in patients with Type 2 Diabetes Mellitus has completed.
-
FDA approval · 2022-08-16FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for TOUJEO (insulin glargine) from Sanofi-Aventis U.S. LLC, resulting in updated labeling for th…
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: Canagliflozin-Mealtime Insulin Rescue [Phase 4]
Phase 4 trial update evaluating canagliflozin in combination with mealtime insulin for type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia [Phase 3]
Clinical trial update for Berlim 25/10 in Type 2 Diabetes Mellitus and Dyslipidemia (Phase 3) with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Symbiotics and Systemic Inflammation in Chronic Kidney Disease [Phase 2]
Phase 2 clinical trial exploring symbiotics effects on systemic inflammation in chronic kidney disease with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Liraglutide for HIV-associated Neurocognitive Disorder [Phase 4]
Phase 4 trial of liraglutide for HIV-associated neurocognitive disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial update examining whether liraglutide reduces endoplasmic reticulum stress in obese patients with type 2 diabetes.
-
CLINICAL_TRIALS withdrawal · 2022-07-27Clinical Trial Update: Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus. [Phase 3]
A Phase 3 clinical trial investigating the efficacy and safety of Lima Association for Type 2 diabetes mellitus was withdrawn.